Skip to main content

Table 5 Relation between HCC recurrence and different parameters in group II

From: Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence

 HCC recurrenceTest of Sig.p
No (n = 19), no. (%)Yes (n = 31), no. (%)
Focal lesion
 110 (52.6%)23 (74.2%)χ2 = 2.583p = 0.227
 26 (31.6%)5 (16.1%)
 33 (15.8%)3 (9.7%)
Overall size (cm)
 Min.–Max.2.20–8.01.30–7.50t = 1.6530.105
 Mean ± SD4.10 ± 1.643.40 ± 1.32
 Median4.03.0
BCLC
 02 (7%)0 (0.0%)χ2=0.075
 A7 (36.8%)19 (61.3%)
 B10 (52.6%)12 (38.7%)
HCC treatment
 Hepatic resection7 (36.8%)5 (16.1%)χ2 = 3.207p = 0.049
 RFA11 (57.8%)24 (77.4%)χ2 = 3.3110.069
 Alcohol injection1 (5.2%)2 (6.5%)χ2 = 0.5430.461